Market Overview:
The global atrial fibrillation treatment device market is expected to grow from USD 2.5 billion in 2018 to USD 4.1 billion by 2030, at a CAGR of 6.4% during the forecast period. The growth of this market can be attributed to the increasing prevalence of atrial fibrillation, technological advancements in atrial fibrillation treatment devices, and rising geriatric population. However, the high cost of these devices may restrain the growth of this market to some extent during the forecast period. Based on type, the global atrial fibrillation treatment device market is segmented into catheter ablation and maze surgery. The catheter ablation segment is expected to grow at a higher CAGR than that for maze surgery during the forecast period owing to its growing popularity among patients with AFib and technological advancements in this area such as 3D mapping systems and contact-force sensing catheters that help reduce procedure time and improve outcomes.
Product Definition:
Atrial Fibrillation Treatment Device is a medical device used to treat atrial fibrillation. It delivers electrical shocks to the heart in an effort to restore a normal heart rhythm.
Catheter Ablation:
Atrial fibrillation is a type of cardiac arrhythmia, which is caused by irregular electrical activities in the atria. The device used for ablation or excisional procedures on the atria is called as catheter ablation or endoscopic catheterization system. It’s majorly used for treatment of slow heartbeats (bradycardia).
Maze Surgery:
Maze surgery is a minimally invasive surgical procedure used to treat atrial fibrillation. It involves mapping the electrical activity of the heart and then cutting off all abnormal pathways. The objective of this surgery is to normalize the electrical activities in the heart, which will help reduce blood clots and improve blood flow through effective removal of blocksage in small veins.
Application Insights:
Based on application, the global atrial fibrillation treatment device market is segmented into hospitals, ambulatory surgical centers and other. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and highly skilled medical staff. Moreover, adoption of these devices in hospitals results in less invasive surgeries which are safer for patients as compared to traditional open heart surgeries.
Ambulatory surgical centers (ASCs) are anticipated to be fastest growing segment over the forecast period due to increasing number of procedures being performed by these centers without any hospitalization requirement. ASCs have high-tech equipment which allows surgeons perform complex procedures with ease thus resulting in increased demand for such devices among patients living far away from major cities where only large hospitals exist or where there aren't enough skilled doctors available locally that can perform complex cardiac surgeries safely and effectively thus driving growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing prevalence of AF, rising adoption of minimally invasive surgeries, and high healthcare expenditure in this region. Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to improving economic conditions and growing awareness about AF treatment options. Moreover, an increase in per capita income coupled with rise in consumer disposable income will boost demand for advanced medical devices over the forecast period.
Major players operating in this space include Medtronic; St. Jude Medical; Abbott; Boston Scientific Corporation; Biotronik AG & Co.; Fresenius Kabi plc.; Johnson & Johnson Services Inc.; Philips Healthcare Belgium Nederland BV; Koninklijke Philips N.V.; Medtronic PLC- ADR (USD X); Merck & Co.
Growth Factors:
- Increasing prevalence of atrial fibrillation
- Growing geriatric population
- Rising awareness about the benefits of atrial fibrillation treatment devices
- Technological advancements in atrial fibrillation treatment devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Atrial Fibrillation Treatment Device Market Research Report
By Type
Catheter Ablation, Maze Surgery
By Application
Hospitals, Ambulatory Surgical Centers, Other
By Companies
Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, Synaptic Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Atrial Fibrillation Treatment Device Market Report Segments:
The global Atrial Fibrillation Treatment Device market is segmented on the basis of:
Types
Catheter Ablation, Maze Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Abbott
- Medtronic
- Japan Lifeline
- Boston Scientific
- Atricure
- Biotroik
- OSYPKA AG
- Cardiofocus
- MicroPort EP MedTech
- Synaptic Medical
Highlights of The Atrial Fibrillation Treatment Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Catheter Ablation
- Maze Surgery
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Atrial Fibrillation Treatment Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Atrial Fibrillation Treatment Device is a medical device that helps to reduce the risk of stroke in people with atrial fibrillation.
Some of the major companies in the atrial fibrillation treatment device market are Johnson & Johnson, Abbott, Medtronic, Japan Lifeline, Boston Scientific, Atricure, Biotroik, OSYPKA AG, Cardiofocus, MicroPort EP MedTech, Synaptic Medical.
The atrial fibrillation treatment device market is expected to grow at a compound annual growth rate of 6.4%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Atrial Fibrillation Treatment Device Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Atrial Fibrillation Treatment Device Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Atrial Fibrillation Treatment Device Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Atrial Fibrillation Treatment Device Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Atrial Fibrillation Treatment Device Market Size & Forecast, 2020-2028 4.5.1 Atrial Fibrillation Treatment Device Market Size and Y-o-Y Growth 4.5.2 Atrial Fibrillation Treatment Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Catheter Ablation
5.2.2 Maze Surgery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Atrial Fibrillation Treatment Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Atrial Fibrillation Treatment Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Catheter Ablation
9.6.2 Maze Surgery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Catheter Ablation
10.6.2 Maze Surgery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Catheter Ablation
11.6.2 Maze Surgery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Catheter Ablation
12.6.2 Maze Surgery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Catheter Ablation
13.6.2 Maze Surgery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Atrial Fibrillation Treatment Device Market: Competitive Dashboard
14.2 Global Atrial Fibrillation Treatment Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Abbott
14.3.3 Medtronic
14.3.4 Japan Lifeline
14.3.5 Boston Scientific
14.3.6 Atricure
14.3.7 Biotroik
14.3.8 OSYPKA AG
14.3.9 Cardiofocus
14.3.10 MicroPort EP MedTech
14.3.11 Synaptic Medical